The former subsets play a role in tumour eradication, while Tregs support tumour growth principally through the secretion of TGF-β which suppresses pro-inflammatory and tumourcidal immune cell subsets (Chen et al. 2005). The gene discussed is TGFB1; the disease is neoplasm.